Angiotensin III (human, mouse): RAAS Peptide for Cardiovascular Research

Executive Summary: Angiotensin III (human, mouse) (CAS: 13602-53-4) is a hexapeptide generated by angiotensinase-mediated cleavage of angiotensin II, playing a critical role in the renin-angiotensin-aldosterone system (RAAS) (Oliveira et al., 2025). It mediates approximately 40% of the pressor activity of angiotensin II and fully retains aldosterone-stimulating capability. The peptide interacts with both AT1 and AT2 receptor subtypes, showing relative specificity for AT2. Experimental studies confirm its utility in eliciting pressor and dipsogenic responses in rodent models, making it valuable for cardiovascular and neuroendocrine signaling research. APExBIO provides validated Angiotensin III (human, mouse) (SKU: A1043), supporting robust and reproducible experimental workflows (product page).

Biological Rationale

Angiotensin III (sequence: Arg-Val-Tyr-Ile-His-Pro-Phe) is a physiologically relevant peptide within the RAAS cascade. It is produced from angiotensin II by aminopeptidase A activity in erythrocytes and peripheral tissues (Oliveira et al., 2025). The RAAS system controls blood pressure, electrolyte balance, and fluid homeostasis. Angiotensin III maintains blood pressure and volume by stimulating aldosterone release from the adrenal cortex, suppressing renin secretion, and exerting pressor effects. Its action is partially overlapping yet distinct from angiotensin II, highlighting its unique research value. Researchers leverage Angiotensin III to probe receptor selectivity, dissect pressor responses, and model neuroendocrine feedback in both basic and translational studies.

Mechanism of Action of Angiotensin III (human, mouse)

Angiotensin III binds to both AT1 and AT2 receptor subtypes, with a higher specificity for the AT2 receptor relative to angiotensin II (Oliveira et al., 2025). Upon binding, it triggers downstream signaling that results in vasoconstriction, aldosterone secretion, and modulation of renal sodium handling. The peptide exerts approximately 40% of the pressor activity of angiotensin II in vivo, while fully retaining its aldosterone-inducing effect (see detailed workflow). In neuroendocrine tissues, Angiotensin III also suppresses renin release, forming part of a tightly regulated feedback mechanism. The peptide's interaction with AT2 may underlie vascular, anti-fibrotic, and anti-inflammatory actions, though these require further delineation in specific models. Its ability to induce pressor and dipsogenic responses in rodent brain assays is well documented, making it a benchmark ligand for RAAS research.

Evidence & Benchmarks

• Angiotensin III is generated by N-terminal cleavage of angiotensin II via angiotensinase activity in erythrocytes and tissues (DOI:10.3390/ijms26136067).
• The peptide mediates ~40% of the pressor activity of angiotensin II in vivo (rodent, 25°C, isotonic buffer) (DOI:10.3390/ijms26136067).
• Angiotensin III retains full aldosterone-stimulating capability compared to angiotensin II in adrenal assays (rat, pH 7.4, 37°C) (DOI:10.3390/ijms26136067).
• It binds both AT1 and AT2 receptor subtypes, with relative specificity for AT2 in competitive binding studies (DOI:10.3390/ijms26136067).
• Exogenous Angiotensin III induces dose-dependent pressor and dipsogenic responses in rodent brain injection models (DOI:10.3390/ijms26136067).
• APExBIO's Angiotensin III (human, mouse) (SKU: A1043) is validated for high solubility: ≥23.2 mg/mL in water, ≥43.8 mg/mL in ethanol, and ≥93.1 mg/mL in DMSO (product page).

For advanced scenario-driven application guidance, see Optimizing Cardiovascular and Neuroendocrine Assays, which focuses on assay reproducibility, while this article expands on molecular mechanisms and benchmarks.

Applications, Limits & Misconceptions

Angiotensin III (human, mouse) is widely used for:

• Modeling aldosterone secretion and pressor activity in cardiovascular and hypertension research.
• Dissecting AT1 and AT2 receptor pathways in cell-based and in vivo assays (see receptor selectivity analysis; this article delves deeper into RAAS signaling context).
• Neuroendocrine signaling studies, particularly in rodent brain models.
• Investigating RAAS involvement in viral pathogenesis, including SARS-CoV-2 spike protein interactions (Oliveira et al., 2025).

Common Pitfalls or Misconceptions

• Angiotensin III is not functionally identical to angiotensin II; pressor activity is lower (~40%), though aldosterone stimulation is equivalent.
• It should not be used for long-term solution storage due to instability; store lyophilized at -20°C as per APExBIO guidelines (product documentation).
• The peptide’s receptor selectivity profile differs from angiotensin II—AT2 effects may predominate, especially at certain concentrations.
• Not suitable as a direct substitute in all RAAS assays; experimental context must dictate peptide choice.
• Solubility varies by solvent; confirm compatibility with assay conditions (water ≥23.2 mg/mL, ethanol ≥43.8 mg/mL, DMSO ≥93.1 mg/mL).

Workflow Integration & Parameters

Angiotensin III (human, mouse) integrates effectively into cardiovascular and neuroendocrine research workflows. The peptide is supplied as a stable lyophilized solid, with a molecular weight of 931.09 Da and formula C₄₆H₆₆N₁₂O₉ (A1043 kit). For preparation, dissolve at ≥23.2 mg/mL in water, ≥43.8 mg/mL in ethanol, or ≥93.1 mg/mL in DMSO. Store desiccated at -20°C and avoid long-term storage in solution. Typical experimental concentrations range from 10 nM to 10 μM, depending on assay sensitivity and receptor expression. APExBIO’s validated product ensures batch-to-batch consistency, critical for reproducibility. For advanced troubleshooting and emerging applications, Angiotensin III: The Essential Peptide for RAAS and Cardi... emphasizes translational and COVID-19 related uses; the present article extends this by focusing on molecular and receptor-level mechanisms.

Conclusion & Outlook

Angiotensin III (human, mouse) is a precise, reliable tool for dissecting RAAS signaling, modeling cardiovascular disease, and investigating neuroendocrine regulation. Its unique receptor interactions and benchmarked activity profile distinguish it from other RAAS peptides, supporting robust experimental design. APExBIO’s A1043 product enables high-fidelity research across diverse platforms, with validated solubility and storage parameters. Ongoing research continues to clarify the roles of Angiotensin III in viral pathogenesis and receptor signaling, underscoring its translational importance (Oliveira et al., 2025).